Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Galati

49 clinical trials in Galati, Romania across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Galati at a glance
49
clinical trials
  • Paediatric trials0
  • Research sites2
Type of trial
Recruitment status
Quick filters

49 trials in Galati

Open in trial search

Phase III Randomized Study of Balcinrenone and Dapagliflozin Versus Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease Stage 3b‑4

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB

Phase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Atebimetinib
  • Sponsor:Immuneering Corp.

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:ZL-1310
  • Sponsor:Zai Lab (US) LLC

Cachexia

Recruiting

A Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Visugromab
  • Sponsor:CatalYm GmbH

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Efficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:NBI-1065890
  • Sponsor:Neurocrine Biosciences Inc.

Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Schizophrenia

Recruiting

Efficacy and safety of roluperidone versus drug combination in adults with schizophrenia with negative symptoms

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Aripiprazole
  • Sponsor:Minerva Neurosciences Inc.

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Galati

What the registry says about research in the country

01 Metabolic Disorders

Innovative research focusing on Type 2 Diabetes and metabolic conditions, evaluating new therapeutic approaches including tirzepatide and orforglipron treatments. Studies aim to improve glycemic control and assess cardiovascular outcomes.

  • Type 2 Diabetes Management
  • Glycemic Control Optimization
  • Cardiovascular Risk Assessment

Multiple trials are exploring combination therapies with existing treatments like insulin glargine.

02 Autoimmune Conditions

Clinical investigations centered on Systemic Lupus Erythematosus, testing novel treatments including dapirolizumab pegol and BMS-986165 to evaluate long-term safety and efficacy.

  • Lupus Treatment Innovation
  • Long-term Safety Studies
  • Immune System Modulation

Research focuses on developing sustainable treatment options for chronic autoimmune conditions.

03 Liver and Metabolic Health

Comprehensive studies addressing Non-alcoholic Steatohepatitis and chronic hepatitis conditions, investigating innovative treatments including semaglutide and bepirovirsen.

  • Liver Disease Management
  • NASH Treatment
  • Hepatitis B Therapy

Trials aim to improve liver histology and reduce disease progression.

04 Weight Management

Advanced research on obesity and related conditions, studying new therapeutic options including retatrutide for weight management and associated complications.

  • Obesity Treatment
  • Weight Management Solutions
  • Metabolic Health Optimization

Studies include evaluation of treatments for obesity-related conditions like knee osteoarthritis.

05 Mental Health

Innovative research addressing Major Depressive Disorder with a focus on anhedonia, testing new adjunctive therapies like aticaprant alongside traditional antidepressants.

  • Depression Treatment
  • Relapse Prevention
  • Combination Therapy Approaches

Studies aim to enhance treatment outcomes for patients with moderate-to-severe symptoms.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.